Compass Pathways on Psychedelic Medicine: independent media talks with Divergent States

Compass Pathways discusses psychedelic medicine with independent media in a Divergent States episode focused on therapeutic development. The conversation centers on how psilocybin-based treatment is positioned for clinical use, including the company perspective on research progress, evidence, and what an effective pathway from trials to real-world care could look like. The episode also frames psychedelics in the broader mainstream conversation, touching on communication, public understanding, and the practical implications of bringing psychedelic therapies into healthcare systems.